SARS-CoV-2 antibody testing—questions to be asked

…, S Holdenrieder, M Kiehntopf, M Neumaier… - Journal of Allergy and …, 2020 - Elsevier
Severe acute respiratory syndrome coronavirus 2 infection and development of coronavirus
disease 2019 presents a major health care challenge of global dimensions. Laboratory …

Approaching clinical proteomics: current state and future fields of application in fluid proteomics

…, S Müllner, W Mutter, M Neumaier… - Clinical chemistry and …, 2009 - degruyter.com
The field of clinical proteomics offers opportunities to identify new disease biomarkers in
body fluids, cells and tissues. These biomarkers can be used in clinical applications for …

Fundamentals of quality assessment of molecular amplification methods in clinical diagnostics

M Neumaier, A Braun, C Wagener… - Clinical …, 1998 - academic.oup.com
The increasing interest in molecular biology diagnostics is a result of the tremendous gain
of scientific knowledge in genetics, made possible especially since the introduction of …

Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy

…, A Bierhaus, P Nawroth, D Hannak, M Neumaier… - Nature medicine, 2003 - nature.com
Three of the major biochemical pathways implicated in the pathogenesis of hyperglycemia
induced vascular damage (the hexosamine pathway, the advanced glycation end product (…

Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction.

…, HW Schreiber, C Wagener, M Neumaier - Journal of Clinical …, 1994 - ascopubs.org
PURPOSE To establish a sensitive assay for the specific detection of carcinoembryonic antigen
(CEA)-expressing tumor cells in the bone marrow of patients with colorectal cancer and …

The toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype

…, T Werfel, U Herz, K Heeg, M Neumaier… - Journal of Allergy and …, 2004 - jacionline.org
Atopic dermatitis (AD) is a common chronic inflammatory skin disease that is part of the
atopic syndrome. Although great progress has been achieved in understanding the …

Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers

…, W Chen, A Raubitschek, LE Williams, M Neumaier… - Immunotechnology, 1996 - Elsevier
Background: Genetic engineering can produce novel antibody fragments with improved
properties for applications such as tumor targeting in vivo. Objectives: To produce stable …

CD66a (BGP), an adhesion molecule of the carcinoembryonic antigen family, is expressed in epithelium, endothelium, and myeloid cells in a wide range of normal …

F Prall, P Nollau, M Neumaier… - … of Histochemistry & …, 1996 - journals.sagepub.com
CD66a, also called biliary glycoprotein (BGP), is a member of the carcinoembryonic antigen
(CEA) family and of the immunoglobulin superfamily. CD66a is the human homologue of …

Biliary glycoprotein, a potential human cell adhesion molecule, is down-regulated in colorectal carcinomas.

M Neumaier, S Paululat, A Chan… - Proceedings of the …, 1993 - National Acad Sciences
Biliary glycoprotein (BGP) is the human homologue of a cell adhesion molecule (CAM) of
the rat designated Cell-CAM. The BGP gene is a member of the carcinoembryonic antigen …

l-Carnosine, a Substrate of Carnosinase-1, Influences Glucose Metabolism

…, G Yuan, GS Braun, M Deinzer, M Neumaier… - Diabetes, 2007 - Am Diabetes Assoc
OBJECTIVE—Carnosinase 1 (CN1) is a secreted dipeptidase that hydrolyzes l-carnosine.
Recently, we have identified an allelic variant of human CN1 (hCN1) that results in increased …